Yuvraj

Johnson & Johnson - J&J has completed the acquisition of Halda Therapeutics which is a clinical-stage biotechnology firm for an amount of $3.05bn in cash. This...

Understanding the critical role of containment isolators, biosafety cabinets, and specialized infrastructure in protecting operators and maintaining product integrity during high-potency API manufacturing requires examining regulatory frameworks, engineering controls, and facility design principles that define modern pharmaceutical safety standards.

Modern pharmaceutical manufacturing demands adaptable infrastructure capable of rapid reconfiguration to accommodate changing production requirements, making modular and portable laboratory equipment essential for contract manufacturers, clinical trial operations, and organizations pursuing capacity expansion through scalable platform technologies.

Temperature-sensitive biologics, advanced therapeutics, and pharmaceutical research materials demand specialized cold storage infrastructure spanning ultra-low temperature freezers, controlled-rate freezing systems, and validated stability chambers that maintain precise thermal conditions throughout research, development and testing workflows.

Celltrion on January 02, 2026, announced that it has completed the transfer of the biopharmaceutical production facility of Eli Lilly that’s located in Branchburg,...

In the most recent of a string of announcements ahead of the holiday season, Centers for Medicare & Medicaid Services (CMS) has unveiled a new...

NICE has gone ahead and cleared the way for bevacizumab to be used by NHS in order to treat colorectal cancer for the very...